Most Popular Papers*
Cardiac Implantable Electronic Device Infections in Saudi Arabia: Incidence, Timing, Causative Organisms, and Outcomes – A Multicenter Study
Saad Albogami, Wael Alqarawi, Ahmed Alfagih, Hiatham Alenzi, Mohammad Alshehri, Mossab Aljuaid, Saeed Alqahtani, Norah Alswaidan, Mohammad Alharbi, Norah Alkaltham, Lama Alasmri, Rghd Sadkh, Muna Albashari, Nour Alhouda, and Imad Tleyjeh
Cardiovascular Disease in Saudi Arabia: facts and the way forward
Adel Abdulkader Tash and Rasha Fahad Al-Bawardy
National Heart Center/Saudi Heart Association 2023 Guidelines on the Management of Hypertension
Waleed Alhabeeb, Adel Abdulkader Tash, Mostafa Alshamiri, Mohamed Arafat, Mohammed Ali Balghith, Ali ALmasood, Abdulla Eltayeb, Hossam Elghetany, Taher Hassan, and Owayed Alshemmari
Anthracyclines and the heart: A double-edged sword with therapeutic hopes
Tariq Majed Alotaibi; Ahmad Mohammad Samman; Abdullah Abdulaziz Al Ghamdi,; Fisal Salah Alkhamis; Faisal Abdulaziz Alnuwaiser; Abdulrhman bin Abdullah Alabdulgader; and Ahmed Hamad Al Jazirri
Caffeine and arrhythmias: A critical analysis of cardiovascular responses and arrhythmia susceptibility
Adel Khalifa Sultan Hamad
A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus
Waleed Alhabeeb, Abdelfatah Elasfar, Abdulhalim Kinsara, Ahmed Aljizeeri, Ibrahim Jelaidan, Kamal Alghalayini, Mohammed F. AlKheraiji., Mousa Akbar, Sameh Lawand, Sarah M. Alyousif, Saud Alsifri, and Taher Hassan
Comparison of Patent Foramen Ovale Closure vs Medical Therapy for the Prevention of Recurrent Cryptogenic Stroke: A Systematic Review
Omar Hamodata; Saif , Almuzainy; Rand Yahya; and Salam Koniali
Long-Term Survival in Lung Cancer with Brain Metastases and Coronary Artery Stenosis: A Case Report
Raghad O. Alharbi, Shahad J. AlShammary, Nasser E. Alotaibi, Ruba M. Aljohani, Bader A. Alotaibi, and Ihab F. Suliman
Ischemia and Anatomy in the New 2024 European Guidelines for Chronic Coronary Syndromes: Update and Comparison of Recommendations
Christian Adrián Caroli
Efficacy and Safety of Olezarsen in Dyslipidemia: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials
Christopher D. Tristan, Risalina Myrtha, Matthew A. Wijayanto, Erlangga M. Kynaya, Muhammad F. Hamka, Nathania E. Sudiono, Muhammad A. Rusyidi, and Muhana F. Ilyas
* Based on the average number of full-text downloads per day since the paper was posted.